Candesartan Tablet
Product Images NDC 33342-115

14 FDA label images from Macleods Pharmaceuticals Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Candesartan (NDC 33342-115). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lab (Candesartan Cantainer 4mg 30s)

Lab (Candesartan Cantainer 4mg 30s)
Label for Candesartan Cilexetil Tablets, USP 4 mg oral tablets, containing 30 tablets per container. Manufactured by Macleods Pharmaceuticals Ltd., Daman, India, and labeled for Macleods Pharma USA, Inc. Storage instructions and reminder to see prescribing information are included. Features NDC 33342-114-07 with barcodes and batch/expiration date fields.*
FDA Label Image

Lab (Candesartan Carton 16mg 100s)

Lab (Candesartan Carton  16mg 100s)
Packaging label for Candesartan Cilexetil Tablets, USP 16 mg oral tablets. The label shows the product name, strength (16 mg), quantity (100 tablets in unit dose blister packs), and manufacturer information for Macleods Pharmaceuticals Limited and Macleods Pharma USA, Inc. Storage instructions and dosage referral to prescribing information are also visible.*
FDA Label Image

Lab (Candesartan Carton 32mg 100s)

Lab (Candesartan Carton 32mg 100s)
Packaging label for Candesartan Cilexetil Tablets, USP 32 mg, an oral tablet product by Macleods Pharmaceuticals Limited. The label shows 100 tablets in unit dose packaging (10 x 10). It includes manufacturer and distributor information, NDC 33342-117-12, and storage instructions. The dosage strength is prominently displayed in orange.*
FDA Label Image

Lab (Candesartan Carton 4mg 100s)

Lab (Candesartan Carton 4mg 100s)
Packaging label for Candesartan Cilexetil Tablets, USP 4 mg, manufactured by Macleods Pharmaceuticals Limited for Macleods Pharma USA, Inc. The label shows the product name, strength (4 mg), dosage form as tablets, package size of 100 tablets unit dose (10 x 10), and storage instructions. A barcode and manufacturing details including locations in New Jersey, USA and Daman, India are visible.*
FDA Label Image

Lab (Candesartan Carton 8mg 100s)

Lab (Candesartan Carton 8mg 100s)
Packaging label for Candesartan Cilexetil Tablets, USP 8 mg by Macleods Pharmaceuticals Limited. The label shows a 100-count blister pack (10 x 10 unit dose tablets) with storage instructions and manufacturer details including Macleods Pharma USA and Daman, India. The strength 8 mg is prominently displayed in red boxes on multiple sides.*
FDA Label Image

Lab (Candesartan Container 16mg 30s)

Lab (Candesartan Container 16mg 30s)
Candesartan Cilexetil Tablets USP 16 mg, oral tablet, packaged by Macleods Pharmaceuticals Limited. The label indicates each tablet contains 16 mg of Candesartan Cilexetil and includes storage instructions. The package contains 30 tablets and is manufactured for Macleods Pharma USA, Inc.*
FDA Label Image

Lab (Candesartan Container 16mg 90s)

Lab (Candesartan Container 16mg 90s)
Packaging label for Candesartan Cilexetil Tablets, USP 16 mg oral tablets. The label indicates a 90-tablet count and includes storage instructions and manufacturer information, showing Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. as the manufacturer and labeler respectively.*
FDA Label Image

Lab (Candesartan Container 32mg 30s)

Lab (Candesartan Container 32mg 30s)
Candesartan Cilexetil Tablets USP 32 mg oral tablets label from Macleods Pharmaceuticals Limited. The label indicates a quantity of 30 tablets and includes storage instructions, manufacturer information for Macleods Pharma USA and Macleods Pharmaceuticals Ltd. There is a barcode, batch and expiration date sections, and a dosage guidance note referencing prescribing information.*
FDA Label Image

Lab (Candesartan Container 32mg 90s)

Lab (Candesartan Container 32mg 90s)
Packaging label for Candesartan Cilexetil Tablets, USP 32 mg, oral tablets by Macleods Pharmaceuticals Limited. The label indicates a supply of 90 tablets, with storage instructions and manufacturer information including Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. The label shows barcode and batch/expiration date placeholders.*
FDA Label Image

Lab (Candesartan Container 4mg 90s)

Lab (Candesartan Container 4mg 90s)
Label for Candesartan Cilexetil Tablets USP 4 mg, manufactured by Macleods Pharmaceuticals Limited. The label includes the NDC number 33342-114-10, storage instructions, and package quantity of 90 tablets. It specifies the product is for oral use and contains Candesartan Cilexetil USP 4 mg per tablet.*
FDA Label Image

Lab (Candesartan Container 8mg 90s)

Lab (Candesartan Container 8mg  90s)
Label for Candesartan Cilexetil Tablets, USP 8 mg, manufactured by Macleods Pharma USA, Inc. The label includes dosage information, storage instructions (20° to 25°C, with permitted excursions), and the package contains 90 tablets. It also notes manufacturing by Macleods Pharmaceuticals Ltd., Daman, India, and features barcodes and an area marked 'OPZ AREA 40 X 15 mm'.*
FDA Label Image

Lab (Candesartan Container 8mg 30s)

Lab (Candesartan Container 8mg 30s)
Label for Candesartan Cilexetil Tablets, USP 8 mg by Macleods Pharmaceuticals Limited. The label states the product contains 30 tablets, indicates storage instructions, and includes manufacturer details for Macleods Pharma USA and Macleods Pharmaceuticals Ltd., India. The label features barcodes and space for batch and expiration dates.*
FDA Label Image

Figure-2 (Candesartan Figure 2)

Figure-2 (Candesartan Figure 2)
A forest plot showing hazard ratios with 95% confidence intervals stratified by patient demographics and medical history. It compares Candesartan cilexetil versus placebo across categories including age, sex, race, NYHA class, left ventricular ejection fraction (LVEF), diabetes, hypertension, prior myocardial infarction, atrial fibrillation, and various medication uses. The horizontal axis represents hazard ratios ranging approximately from 0.4 to 1.3, with markers indicating whether Candesartan or placebo is favored.*
FDA Label Image

Lab (Candesartan Structure1)

Lab (Candesartan Structure1)
Chemical structure of Candesartan showing the molecular arrangement with an indication of the site of ester hydrolysis. The structure includes various rings and functional groups characteristic of this active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.